142 related articles for article (PubMed ID: 11113544)
1. Determination of D1 and D2 dopamine receptor expression by Ntera-2 cells.
Sakolsky DJ; Ashby B
Brain Res Mol Brain Res; 2000 Dec; 84(1-2):158-61. PubMed ID: 11113544
[TBL] [Abstract][Full Text] [Related]
2. Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction.
Lee D; Huang W; Lim AT
Mol Psychiatry; 2000 Jan; 5(1):39-48. PubMed ID: 10673767
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
4. Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells.
Lemmer K; Ahnert-Hilger G; Höpfner M; Hoegerle S; Faiss S; Grabowski P; Jockers-Scherübl M; Riecken EO; Zeitz M; Scherübl H
Life Sci; 2002 Jun; 71(6):667-78. PubMed ID: 12072155
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
6. Patterns of cyclic AMP formation by coexpressed D1 and D2L dopamine receptors in HEK 293 cells.
Sakolsky DJ; Ashby B
Recept Channels; 2001; 7(6):479-89. PubMed ID: 11918350
[TBL] [Abstract][Full Text] [Related]
7. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors.
Wang JQ; McGinty JF
J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells.
Sidhu A; Olde B; Humblot N; Kimura K; Gardner N
Neuroscience; 1999; 91(2):537-47. PubMed ID: 10366011
[TBL] [Abstract][Full Text] [Related]
9. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.
Perachon S; Schwartz JC; Sokoloff P
Eur J Pharmacol; 1999 Feb; 366(2-3):293-300. PubMed ID: 10082211
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D3 receptors in rat juxtaglomerular cells.
Sanada H; Yao L; Jose PA; Carey RM; Felder RA
Clin Exp Hypertens; 1997; 19(1-2):93-105. PubMed ID: 9028638
[TBL] [Abstract][Full Text] [Related]
11. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
[TBL] [Abstract][Full Text] [Related]
12. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.
Harvey J; Lacey MG
J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):143-54. PubMed ID: 8730590
[TBL] [Abstract][Full Text] [Related]
13. Increased sensitivity in the interaction of the dopaminergic/adenosinergic system at the level of the adenylate cyclase activity in the striatum of the "weaver" mouse.
K B; V T; N P; M M; N M; F A
Neurochem Int; 2016 Oct; 99():233-238. PubMed ID: 27498335
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2.
Verma V; Hasbi A; O'Dowd BF; George SR
J Biol Chem; 2010 Nov; 285(45):35092-103. PubMed ID: 20807772
[TBL] [Abstract][Full Text] [Related]
15. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
Kozell LB; Machida CA; Neve RL; Neve KA
J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941
[TBL] [Abstract][Full Text] [Related]
16. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
Coronas V; Krantic S; Jourdan F; Moyse E
Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
[TBL] [Abstract][Full Text] [Related]
18. Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue.
Pinna A; Morelli M; Drukarch B; Stoof JC
Eur J Pharmacol; 1997 Jul; 331(1):23-6. PubMed ID: 9274925
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activity of a chimeric D2/D1 dopamine receptor.
Kozell LB; Neve KA
Mol Pharmacol; 1997 Dec; 52(6):1137-49. PubMed ID: 9396784
[TBL] [Abstract][Full Text] [Related]
20. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
